Fertility Testing for Women: The Standard Workup, Step by Step

It usually starts at midnight. A birthday has just passed, 33, maybe 36, and somewhere between a friend’s pregnancy announcement and a targeted ad, you find yourself comparing at-home hormone kits, each promising to reveal your “fertility score” from a finger prick.

Here’s what those ads don’t say: fertility isn’t one number, and it can’t be captured by one vial of blood. It’s a chain of events: an egg maturing, releasing, traveling down an open tube, meeting sperm, and implanting in a receptive uterus. A proper workup checks each link in that chain, one step at a time.

The good news is that the standard evaluation is neither mysterious nor endless. It follows a well-worn sequence that most clinicians complete within one or two menstrual cycles. This is that sequence, laid out in order, with honest notes about what each result can and cannot tell you.

How do I test if I'm fertile as a woman?

The honest answer: you can’t, not with a single test. What medicine offers instead is a structured evaluation that examines each requirement for conception separately. Are you releasing an egg each month? Is your remaining egg supply roughly typical for your age? Are your fallopian tubes open? Is the uterine cavity normal? And, because it takes two, is your partner’s sperm count and quality adequate?

Each question has its own test, and the answers matter in combination, not isolation. A woman with a robust egg supply but blocked tubes cannot conceive without help; a woman with a modest egg supply and open tubes very often can. That’s why clinicians resist giving anyone a single “fertility grade.”

The sequence generally runs like this: a detailed history first, then blood work timed to specific days of your cycle, then a transvaginal ultrasound, then, if the picture warrants it, an imaging study of the tubes. A semen analysis for a male partner runs in parallel from day one, not as an afterthought. According to the Mayo Clinic, this core workup identifies a probable cause in the majority of couples evaluated.

Think of it less like a pass/fail exam and more like a systems check on a car: several small inspections, each looking at one part that has to work for the whole thing to run.

When should you start fertility testing?

The timing rules are more specific than most people realize, and they hinge on age. Under 35, the standard advice is to try for 12 months before seeking an evaluation, because roughly 8 to 9 out of 10 couples in that group conceive within a year. At 35 or older, the window shortens to 6 months. At 40 and beyond, many clinicians recommend an evaluation as soon as you decide to try, or even before.

Why the compressed timeline? Egg quality declines measurably through the late 30s, so a year spent waiting carries a real cost that it doesn’t carry at 28.

Some situations justify skipping the waiting period entirely, regardless of age:

• Periods that are irregular, very far apart, or absent
• A known diagnosis of endometriosis, polycystic ovary syndrome, or pelvic inflammatory disease
• Prior pelvic or abdominal surgery, or a history of chemotherapy or radiation
• Two or more miscarriages
• A partner with known or suspected sperm issues

One more group deserves mention: people not trying to conceive yet who simply want information for planning. Testing in that situation is reasonable, but the results, especially ovarian reserve markers, need careful interpretation, because they forecast supply, not your odds of conceiving this year. More on that shortly.

Step one isn't a test at all: it's the conversation

Before anyone draws blood, a good clinician will spend a surprising amount of time just asking questions. This isn’t small talk. The history often narrows the diagnosis faster than any lab panel.

Expect questions about your cycle: how many days from the start of one period to the start of the next, how regular that interval is, how heavy the bleeding runs, and whether periods are painful enough to interfere with life. A cycle that reliably arrives every 26 to 32 days is strong indirect evidence that ovulation is happening. Cycles that swing wildly, 24 days one month, 45 the next, point toward an ovulation problem before a single hormone is measured.

You’ll also be asked about past pregnancies and miscarriages, sexually transmitted infections, surgeries, chronic conditions like thyroid disease or diabetes, medications, and family history, particularly early menopause in your mother or sisters, which can run in families. Lifestyle questions about smoking, alcohol, and how often intercourse is timed to the fertile window are standard, not judgmental.

Bring notes. If you’ve tracked cycles in an app, export a summary. If you’ve had prior lab work, request the actual numbers, not just “it was normal.” A well-prepared first visit can compress the entire workup by a month, because the clinician can order cycle-timed tests immediately instead of waiting to learn your pattern.

The blood panel: which hormones, and when in your cycle

Timing is everything with fertility blood work: the same hormone can look “abnormal” or “reassuring” depending on which day it’s drawn. That’s the main reason mail-order panels drawn on a random Tuesday can mislead.

Test	Typical timing	What it reflects
FSH + estradiol	Cycle day 2–4	How hard the brain must push the ovaries to recruit an egg; high FSH suggests diminished reserve
LH	Cycle day 2–4	Pattern relative to FSH can hint at polycystic ovary syndrome
AMH	Any day	An estimate of remaining egg supply
TSH	Any day	Thyroid function; imbalances can disrupt ovulation
Prolactin	Any day	When elevated, can suppress ovulation entirely
Progesterone	~7 days before expected period	Confirms that ovulation actually occurred

A few practical notes. FSH and estradiol travel as a pair: a “normal” FSH can be falsely reassuring if estradiol is high that day, which is why labs draw both. AMH is the flexible one; because it comes from small resting follicles rather than the cycling ones, it stays fairly steady across the month. And the thyroid and prolactin checks, per MedlinePlus, catch fixable problems that masquerade as infertility more often than people expect.

The whole panel typically requires two blood draws in a single cycle: one early, one late. That’s it.

AMH and ovarian reserve: useful, but often oversold

Anti-Müllerian hormone has become the celebrity of fertility testing, and it deserves some of the attention. Produced by small follicles waiting in the ovarian queue, AMH gives a reasonable estimate of how many eggs remain, which is genuinely valuable for predicting how the ovaries would respond to IVF stimulation and for flagging unusually early decline.

Here’s what it does not do, and this is where the marketing outruns the evidence: AMH does not predict your chance of conceiving naturally in the near term. A widely cited 2017 study followed women aged 30 to 44 who were trying to conceive and found that those with low AMH became pregnant at essentially the same rate over 12 months as those with normal levels. Conception each month requires one good egg, not a large inventory.

So a low AMH at 32 is information, not a verdict. It may reasonably influence how long you wait before seeking help, or whether you consider egg freezing if pregnancy is years away. It should not, by itself, trigger panic, and a high AMH is not a golden ticket either, since it says nothing about egg quality, tubes, or the uterus. Notably, a high value can also accompany polycystic ovary syndrome rather than signal super-fertility.

MedlinePlus puts it plainly: AMH reflects quantity, and quantity is only one variable in a longer equation. Treat the number as one instrument on the dashboard, not the whole dashboard.

At what age are 90% of your eggs gone? Unpacking a scary statistic

You’ve probably seen the headline: “90% of a woman’s eggs are gone by 30.” It’s technically rooted in real research, and profoundly misleading without context.

The figure traces to a 2010 mathematical modeling study that estimated, based on pooled data, that by age 30 the average woman retains about 12% of the ovarian follicles she had before birth, falling to roughly 3% by 40. Headlines rounded 88% to 90% and dropped the denominator.

Here’s the denominator: a female fetus carries somewhere between one and two million eggs at birth. Twelve percent of that is still on the order of 100,000 to 200,000 eggs at age 30. Across an entire reproductive lifetime, only about 300 to 400 eggs are ever actually ovulated. The supply was always destined to shrink dramatically: that’s normal ovarian biology, not a malfunction.

What matters far more for conception odds is egg quality, which declines meaningfully from the mid-30s onward as chromosomal errors become more common. That’s why fertility drops with age even in women with plentiful AMH, and why a 41-year-old with a “good” ovarian reserve still faces steeper odds per cycle than a 31-year-old with a modest one.

The evidence-based takeaway: age is the single strongest predictor of female fertility, but the “90% gone” framing converts an ordinary biological curve into unnecessary dread. You don’t need 100,000 eggs this month. You need one.

Am I actually ovulating? The mid-luteal progesterone check

Ovulation problems account for a substantial share of female infertility, the NHS lists them among the most common identifiable causes, and conveniently, they’re among the easiest to detect.

The workhorse test is a single progesterone blood draw timed to the middle of the luteal phase, about seven days before your expected period. In a textbook 28-day cycle that’s day 21, which is why you’ll hear it called the “day 21 test.” The label misleads people with longer cycles: if your cycles run 35 days, the correct draw is around day 28. Progesterone comes from the structure left behind after an egg is released, so a clearly elevated level is direct chemical proof that ovulation happened that cycle. A flat, low level suggests it didn’t, or that the timing of the draw missed the window, which is why the test is sometimes repeated.

Clues you can gather yourself carry real, if softer, evidence: regular cycles, mid-cycle changes in cervical mucus toward a slippery egg-white texture, a sustained rise of a few tenths of a degree in basal body temperature after ovulation, and positive urine LH surges. None of these individually proves a healthy ovulatory cycle, but together with a mid-luteal progesterone they build a convincing picture.

One caution worth stating clearly: a temperature rise confirms ovulation only after the fact. It’s useful for diagnosis, far less useful for timing intercourse in real time.

The transvaginal ultrasound and antral follicle count

Blood tests estimate; ultrasound looks. A transvaginal ultrasound: a slim probe, a few minutes, typically no more uncomfortable than a routine pelvic exam, lets the clinician directly inspect the ovaries and uterus, and it earns its place in the standard workup several times over.

The headline measurement is the antral follicle count, or AFC: the number of small resting follicles (roughly 2 to 10 millimeters) visible across both ovaries early in the cycle. Each of those follicles houses an immature egg, so the count serves as a visual cross-check on AMH. The two usually agree; when they don’t, clinicians weigh both rather than trusting either alone.

The same scan surveys the neighborhood. It can reveal:

• Ovarian cysts, including the endometriomas associated with endometriosis
• A polycystic ovarian appearance, many small peripheral follicles, that supports a PCOS diagnosis alongside history and labs
• Uterine fibroids, and critically, whether they bulge into the cavity where an embryo would implant
• A thickened or irregular uterine lining that warrants a closer look

Timing matters here too: the AFC is most reliable in the first few days of the cycle, before a dominant follicle emerges and crowds the picture. Many clinics schedule the scan and the day 2–4 blood draw for the same visit, which is one reason an organized workup moves faster than a piecemeal one.

Are the tubes open? The HSG, explained honestly

This is the step no home kit can replicate. The fallopian tubes are where egg and sperm actually meet, and tubes scarred by past infection, endometriosis, or surgery are a common, and completely silent, cause of infertility. Normal periods, normal hormones, normal ultrasound: none of them rules out blocked tubes.

The standard study is a hysterosalpingogram, or HSG. A thin catheter passes through the cervix, a contrast dye flows into the uterus, and an X-ray tracks whether the dye travels through both tubes and spills freely into the pelvis. Free spill on both sides means open tubes. The images also outline the uterine cavity, so the test does double duty, flagging polyps, fibroids, or structural variations.

Now the honest part: it can hurt. Most women describe strong menstrual-type cramping that peaks as the dye goes in and eases within minutes; a minority find it more painful than that. The procedure itself typically takes about five minutes, and taking an over-the-counter pain reliever beforehand, ask your clinician which and when, blunts the worst of it for many people. It’s scheduled after your period ends but before ovulation, to avoid disturbing a possible early pregnancy.

An alternative in many clinics is saline or foam infusion under ultrasound (often called SIS or HyCoSy), which avoids X-rays. Intriguingly, some studies have observed a modest bump in conception rates in the months after tubal flushing: a reminder that this test occasionally does more than diagnose, though it is never performed as a treatment promise.

When do doctors look directly inside?

Most fertility workups stop at blood work, ultrasound, and an HSG. Two further procedures exist for the minority of cases where those first-line tests raise questions they can’t answer, and it’s worth knowing they’re the exception, not the routine.

Hysteroscopy is the gentler of the two. A pencil-thin camera passes through the cervix into the uterus, giving a direct view of the cavity, no incisions. If the HSG or ultrasound hinted at a polyp, a fibroid protruding into the cavity, scar tissue, or a septum, hysteroscopy confirms what’s there, and small findings can often be addressed during the same procedure. It’s frequently done as a brief outpatient visit.

Laparoscopy is a step up: a surgical procedure under general anesthesia in which a camera enters the abdomen through a small incision near the navel. It remains the definitive way to diagnose endometriosis, which imaging can miss entirely, particularly in milder forms, and to assess scar tissue around the tubes and ovaries. Because it carries surgical risks, the Mayo Clinic notes it’s reserved for cases where symptoms (severe period pain, pain with intercourse) or prior findings make hidden pelvic disease genuinely plausible.

If your clinician doesn’t recommend either procedure, that’s usually good news: it means the noninvasive tests told a coherent story. And if one is recommended, the reasonable questions to ask are simple ones, what specifically are we looking for, and how would finding it change the plan?

Can I test myself for fertility at home?

Partially, and the word “partially” is doing heavy lifting in that sentence.

What home testing genuinely can do: mail-in finger-prick kits can measure AMH and sometimes thyroid and other hormones with reasonable laboratory accuracy. Urine LH kits can detect the surge that precedes ovulation. Basal body temperature and cervical mucus tracking can build a months-long record of whether your cycles look ovulatory. That’s real information, and bringing it to a first appointment is useful.

What home testing cannot do is the second half of the workup: the half that most often holds the answer. No kit can:

• Determine whether your fallopian tubes are open
• Count antral follicles or examine your ovaries and uterus
• Detect endometriosis, fibroids, or polyps
• Interpret a hormone value in the context of your history, cycle day, and ultrasound

There’s also a subtler problem: results without interpretation. A slightly low AMH delivered by email at 11 p.m., with no clinician to explain that AMH doesn’t predict natural conception, has sent a lot of people into needless spirals, and a “normal” panel has falsely reassured others whose actual issue was tubal or male-factor.

A fair verdict: home tests are a reasonable preview, a poor substitute. If the results worry you, or if you’ve been trying for the timeframes discussed earlier, the next step is a clinician, not another kit.

What ovulation kits and cycle apps can, and can't, tell you

Ovulation predictor kits are the most evidence-friendly of the consumer tools. They detect the surge of luteinizing hormone in urine that occurs roughly 24 to 36 hours before an egg is released, which makes them genuinely useful for timing intercourse during the fertile window: the five days before ovulation plus ovulation day itself.

Their limits are specific and worth knowing. In polycystic ovary syndrome, chronically elevated LH can produce misleading positives. A detected surge also doesn’t guarantee an egg was actually released; occasionally the surge occurs without ovulation following. And a month of negative strips might mean no ovulation, or might mean testing missed a short surge, which can last less than a day.

Cycle-tracking apps deserve a more skeptical eye. Most predict ovulation from calendar math, typically assuming it lands around 14 days before the next period, and studies have found their predicted “fertile windows” frequently miss the mark, especially for anyone with cycle-length variability. An app is a fine diary; it is a mediocre oracle.

Basal body temperature sits in between: a sustained post-ovulation rise of about 0.3 to 0.5°C is decent retrospective evidence that ovulation occurred, and several months of charts can genuinely help a clinician. Just remember its structural flaw, by the time the temperature rises, the fertile window has already closed. Use it to look backward, LH strips to look forward, and blood work to settle the question.

The test that isn't for you: don't skip the semen analysis

Here is the most common structural mistake in fertility evaluation: the woman completes months of blood draws, scans, and an uncomfortable dye study before anyone examines the sperm. It happens constantly, and it’s backwards.

The numbers explain why. According to the CDC and NHS, a male factor contributes to infertility in roughly 40 to 50 percent of couples, and in about a third of cases it’s the primary issue. A semen analysis, one sample, one lab visit, results within days, evaluates sperm count, motility (how well they swim), and morphology (their shape). It is noninvasive, inexpensive relative to nearly everything else in the workup, and capable of redirecting the entire investigation in a single stroke.

Every major guideline therefore places the semen analysis in the first round of testing, ordered at the same time as the female partner’s initial blood work, not held in reserve for later. A man who feels healthy, exercises, and has fathered children before can still have a significant sperm issue today; there is no reliable way to guess from the outside.

Practical notes: labs typically ask for 2 to 7 days of abstinence before the sample, and because sperm parameters fluctuate, an abnormal result is usually repeated a few weeks later before conclusions are drawn. One suboptimal reading is a data point, not a diagnosis.

If you take a single piece of advice from this article into a first appointment, make it this: ask for both halves of the workup to start on the same day.

When to see a doctor, and what to bring

The general timelines bear repeating because they’re the backbone of every guideline: see a clinician after 12 months of regular, unprotected intercourse without conception if you’re under 35, after 6 months if you’re 35 to 39, and promptly at 40 or older.

Don’t wait out those windows if any of the following applies to you:

• Cycles shorter than 21 days, longer than 35, or absent altogether
• Severely painful periods, pain with intercourse, or known/suspected endometriosis
• A history of pelvic infection, sexually transmitted infection, or pelvic surgery
• Two or more pregnancy losses
• Prior chemotherapy or radiation, for either partner
• New symptoms such as unexplained milky nipple discharge, marked hair growth changes, or hot flashes well before the typical age of menopause, each can signal a hormonal issue that deserves evaluation in its own right, pregnancy plans or not

Your first stop can be a primary care clinician or gynecologist; much of the initial workup happens there, with referral to a reproductive specialist if results warrant it.

What to bring: several months of cycle dates, any home test results (including LH strips and temperature charts), a list of medications and supplements, prior lab reports with actual numbers, surgical and infection history, and, ideally, your partner, because his history and testing are half the evaluation. Couples who arrive organized routinely shave weeks off the process, simply because cycle-timed tests can be scheduled immediately.

What if every test comes back normal?

It happens more often than you’d think, and it deserves an honest treatment rather than a shrug. When ovulation is confirmed, tubes are open, the uterus looks normal, and the semen analysis is fine, the label applied is “unexplained infertility.” The NHS estimates it accounts for roughly a quarter of cases.

“Unexplained” is a frustrating word, but it’s worth understanding what it actually means: not that nothing is wrong, but that nothing is wrong at the resolution our current tests can see. The standard workup checks the plumbing and the hormones. It cannot watch a specific egg get fertilized, evaluate an individual embryo’s chromosomes, or observe implantation, steps where subtle problems can hide.

Two evidence-based reassurances belong here. First, an unexplained diagnosis carries a genuinely better outlook than most named causes; a meaningful share of couples with unexplained infertility conceive on their own in the year or two after the workup, particularly younger couples with a shorter duration of trying. Second, “no explanation” does not mean “no options”: it means treatment decisions get made on age, duration, and preference rather than on a specific broken part, a conversation to have with your own clinician.

What normal results emphatically do provide is a map. You’ll know which problems you don’t have, which is not nothing: it’s the difference between wandering and navigating. And if circumstances change, the baseline numbers from this workup make any future evaluation faster and more precise.

Frequently asked questions

How do I test if I'm fertile as a woman?

There’s no single test, fertility is evaluated in parts. A clinician confirms ovulation with a cycle-timed progesterone blood test, estimates egg supply with AMH and an ultrasound follicle count, checks thyroid and prolactin, and verifies the fallopian tubes are open with an X-ray dye study. Regular cycles every 26–32 days are a reassuring sign of ovulation, but they don’t rule out tubal or uterine issues.

How can I test my fertility levels?

Ask a clinician for the standard panel: FSH, LH, and estradiol drawn on cycle day 2–4, AMH on any day, plus thyroid (TSH) and prolactin. A progesterone level about seven days before your expected period confirms ovulation. Timing matters: the same hormone can look normal or abnormal depending on the cycle day it’s drawn, which is why randomly timed panels can mislead.

At what age are 90% of your eggs gone?

Around age 30, according to a 2010 modeling study, but the framing is misleading. Women are born with one to two million eggs, so the remaining ~12% at 30 still means roughly 100,000 or more, while a lifetime of ovulation uses only about 300–400. Egg quality, which declines from the mid-30s onward, matters far more for conception odds than raw quantity.

How can I test myself for fertility at home?

You can gather partial evidence: urine LH kits detect the surge before ovulation, basal body temperature charts confirm ovulation after the fact, and mail-in kits can measure AMH and thyroid hormones. What no home test can do is check whether your tubes are open, count follicles on ultrasound, or detect endometriosis or fibroids, and those are frequent causes. Treat home results as a preview to bring to a clinician, not a verdict.

What is a good AMH level?

Typical ranges vary by age and by lab, so there’s no universal ‘good’ number: a value should always be interpreted against age-matched reference ranges. More importantly, AMH reflects egg quantity, not quality or your near-term chance of natural conception. Research shows women with low AMH conceive naturally at rates similar to those with normal levels. Very high values can accompany polycystic ovary syndrome rather than indicate extra fertility.

What day of my cycle should fertility blood tests be done?

FSH, LH, and estradiol are drawn on day 2, 3, or 4, counting the first day of full flow as day 1. Progesterone is drawn about seven days before your expected period, day 21 of a 28-day cycle, but day 28 of a 35-day cycle. AMH, thyroid, and prolactin can be measured on any day. Most workups need just two draws in a single cycle.

Do regular periods mean I'm fertile?

Not necessarily, though they’re a genuinely good sign. Regular, predictable cycles strongly suggest you’re ovulating, which is one essential requirement. They tell you nothing, however, about whether your fallopian tubes are open, whether the uterine cavity is normal, or whether your partner’s sperm parameters are adequate, three common causes of infertility that produce no menstrual symptoms at all.

Does the HSG tube test hurt?

For most women it causes strong menstrual-like cramping that peaks for a few minutes as the dye passes through and eases quickly afterward; a minority find it more painful. The procedure itself typically takes about five minutes. Taking an over-the-counter pain reliever beforehand, ask your clinician which one and when, helps many people, and some clinics offer a saline-ultrasound alternative that avoids X-rays.

Can fertility tests predict when I'll reach menopause?

Not with useful precision for an individual. AMH and antral follicle counts do trend downward as menopause approaches, and unusually low values at a young age can flag earlier-than-average decline worth discussing. But studies show these markers give wide, imprecise windows when used to forecast a specific woman’s menopause timing. They’re better at describing your supply today than at predicting a date years out.

Does an abnormal fertility test result mean I can't get pregnant?

No single abnormal result means that. Hormone levels fluctuate, so abnormal values are typically repeated before conclusions are drawn; a suboptimal semen analysis is rechecked weeks later; even a blocked tube on HSG is sometimes spasm rather than true blockage. Results are interpreted together, alongside age and history. An abnormal finding narrows the search for a cause: it doesn’t close the door, and next steps are a conversation with your clinician.

References

• NHS: Infertility: Diagnosis
• MedlinePlus: Anti-Müllerian Hormone (AMH) Test
• MedlinePlus: Follicle-Stimulating Hormone (FSH) Levels Test
• MedlinePlus: Infertility

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.